Family history of inflammatory bowel disease in patients with idiopathic ocular inflammation

被引:23
作者
Lin, Phoebe [1 ]
Tessler, Howard H. [1 ]
Goldstein, Debra A. [1 ]
机构
[1] Univ Illinois, Ctr Eye, Chicago, IL 60612 USA
关键词
D O I
10.1016/j.ajo.2006.01.075
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE: To determine the prevalence of a family history (FMH) of inflammatory bowel disease (IBD) in patients with idiopathic ocular inflammation (OI). DESIGN: Retrospective observational study. METHODS: Medical records of idiopathic OI patients seen between January 1995 and June 2005 in the University of Illinois Uveitis Clinic were screened for a FMH of IBD. FMH included first, second, and third degree relatives. RESULTS: 727 (32.8%) patients had idiopathic OI. 26 of 7 2 7 (3.6%) and 10 of 7 2 7 (1.4%) reported a FMH of ulcerative colitis (UC) and Crohn's disease, respectively. 16 (2.2%) patients with a FMH of indeterminate colitis were excluded from subsequent comparisons. The prevalence of a FMH of IBD among patients with idiopathic OI was 3- to 15-fold higher than the prevalence of UC and Crohn's in the general population (0.055% to 0.27%). Keratoiritis was more common and granulomatous disease less frequent in patients with a FMH of IBD (P =.014 and .019). Patients tested 26.3 % with a FMH of IBD, and 66.7% of patients tested with IBD them, selves, were HLA-B27 positive (odds ratio [OR] 5.6, 95% confidence interval [CI] 0.77 to 45.8), compared with 40.1% of patients with neither (OR 1.87, 95% CI 0.61 to 6.83). CONCLUSIONS: A FMH of IBD may be an independent risk factor for the development of OI. In contrast to the subgroup of patients with a personal history of IBD, HLA-B27 may not be an appropriate marker in the subgroup of patients with merely a FMH of IBD, emphasizing the importance of investigating other immunologic factors that may predispose patients with IBD and their relatives to OI.
引用
收藏
页码:1097 / 1104
页数:8
相关论文
共 23 条
[1]  
Anonymous, 2005, International Ophthalmology Clinics, V45, P1, DOI 10.1097/01.iio.0000155938.83083.94
[2]  
Bernstein CN, 2001, AM J GASTROENTEROL, V96, P1116
[3]   ACUTE ANTERIOR UVEITIS - CLINICAL AND EXPERIMENTAL ASPECTS [J].
CARELESS, DJ ;
INMAN, RD .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 1995, 24 (06) :432-441
[4]  
GARLAND CF, 1981, GASTROENTEROLOGY, V81, P1115
[5]   pANCA antibodies in patients with anterior uveitis: Identification of a marker antibody usually associated with ulcerative colitis [J].
Gordon, LK ;
Eggena, M ;
Holland, GN ;
Weisz, JM ;
Braun, J .
JOURNAL OF CLINICAL IMMUNOLOGY, 1998, 18 (04) :264-271
[6]   Drug therapy - Inflammatory bowel disease [J].
Hanauer, SB .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (13) :841-848
[7]   CHANGING PATTERNS OF UVEITIS [J].
HENDERLY, DE ;
GENSTLER, AJ ;
SMITH, RE ;
RAO, NA .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1987, 103 (02) :131-136
[8]   A critical review of epidemiological studies in inflammatory bowel disease [J].
Irvine, EJ ;
Farrokhyar, F ;
Swarbrick, ET .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2001, 36 (01) :2-15
[9]   Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop [J].
Jabs, DA ;
Nussenblatt, RB ;
Rosenbaum, JT .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2005, 140 (03) :509-516
[10]  
JAYANTHI V, 1991, AM J GASTROENTEROL, V86, P1566